BG103252A - The use of benzopyranols for the treatment of neurological disorders - Google Patents
The use of benzopyranols for the treatment of neurological disordersInfo
- Publication number
- BG103252A BG103252A BG103252A BG10325299A BG103252A BG 103252 A BG103252 A BG 103252A BG 103252 A BG103252 A BG 103252A BG 10325299 A BG10325299 A BG 10325299A BG 103252 A BG103252 A BG 103252A
- Authority
- BG
- Bulgaria
- Prior art keywords
- treatment
- pains
- benzopyranols
- neurological disorders
- neuralgia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
| PCT/EP1997/005168 WO1998011890A1 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103252A true BG103252A (en) | 1999-09-30 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103252A BG103252A (en) | 1996-09-18 | 1999-03-15 | The use of benzopyranols for the treatment of neurological disorders |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (de) |
| JP (1) | JP2001500520A (de) |
| KR (1) | KR20000036184A (de) |
| CN (1) | CN1230885A (de) |
| AP (1) | AP9901473A0 (de) |
| AR (1) | AR008838A1 (de) |
| AT (1) | ATE270102T1 (de) |
| AU (1) | AU730465B2 (de) |
| BG (1) | BG103252A (de) |
| BR (1) | BR9712030A (de) |
| CA (1) | CA2266681A1 (de) |
| DE (1) | DE69729735T2 (de) |
| DZ (1) | DZ2311A1 (de) |
| EA (1) | EA199900306A1 (de) |
| ES (1) | ES2223075T3 (de) |
| GB (1) | GB9619492D0 (de) |
| HU (1) | HUP9904638A3 (de) |
| ID (2) | ID23175A (de) |
| IL (1) | IL128786A0 (de) |
| MA (1) | MA24321A1 (de) |
| NO (1) | NO991292D0 (de) |
| NZ (1) | NZ334271A (de) |
| OA (1) | OA10998A (de) |
| PE (1) | PE109898A1 (de) |
| PL (1) | PL332313A1 (de) |
| SK (1) | SK35199A3 (de) |
| TR (1) | TR199900527T2 (de) |
| UY (1) | UY24717A1 (de) |
| WO (1) | WO1998011890A1 (de) |
| ZA (1) | ZA978359B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| CA2726874A1 (en) * | 2008-06-05 | 2009-12-10 | Minster Research Limited | Novel treatments |
| CA2726878A1 (en) * | 2008-06-05 | 2009-12-10 | Minster Research Limited | Novel treatments |
| WO2011067607A1 (en) * | 2009-12-03 | 2011-06-09 | Minster Research Ltd | Treatment of infectious diseases |
| DK2464645T3 (en) | 2009-07-27 | 2017-10-23 | Gilead Sciences Inc | CONDENSED, HETEROCYCLIC COMPOUNDS AS IRON CHANNEL MODULATORS |
| WO2011067608A1 (en) * | 2009-12-03 | 2011-06-09 | Minster Research Ltd | Treatment of allodynia and hyperalgesia |
| BR112012033402A2 (pt) | 2010-07-02 | 2017-01-24 | Gilead Sciences Inc | moduladores de canais de íons conforme os compostos heterocíclicos fundidos |
| US9115096B2 (en) | 2011-05-10 | 2015-08-25 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| NO3175985T3 (de) | 2011-07-01 | 2018-04-28 | ||
| UY34171A (es) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores del canal iónico |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| CZ286081B6 (cs) * | 1994-06-10 | 2000-01-12 | Smithkline Beecham P. L. C. | Benzopyrany a jejich použití jako terapeutických činidel |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Application Discontinuation
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Application Discontinuation
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 EP EP97909300A patent/EP0939630B1/de not_active Expired - Lifetime
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292D0/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4704797A (en) | 1998-04-14 |
| AU730465B2 (en) | 2001-03-08 |
| KR20000036184A (ko) | 2000-06-26 |
| EP0939630A1 (de) | 1999-09-08 |
| DE69729735T2 (de) | 2005-07-14 |
| ID19542A (id) | 1998-07-23 |
| PL332313A1 (en) | 1999-08-30 |
| SK35199A3 (en) | 2000-07-11 |
| CA2266681A1 (en) | 1998-03-26 |
| ZA978359B (en) | 1999-03-17 |
| JP2001500520A (ja) | 2001-01-16 |
| EP0939630B1 (de) | 2004-06-30 |
| DZ2311A1 (fr) | 2002-12-28 |
| BR9712030A (pt) | 1999-08-24 |
| CN1230885A (zh) | 1999-10-06 |
| HUP9904638A3 (en) | 2001-08-28 |
| OA10998A (en) | 2003-03-04 |
| NO991292L (no) | 1999-03-17 |
| NZ334271A (en) | 2001-03-30 |
| AP9901473A0 (en) | 1999-03-31 |
| GB9619492D0 (en) | 1996-10-30 |
| ATE270102T1 (de) | 2004-07-15 |
| AR008838A1 (es) | 2000-02-23 |
| HUP9904638A2 (hu) | 2001-05-28 |
| PE109898A1 (es) | 1999-03-21 |
| IL128786A0 (en) | 2000-01-31 |
| MA24321A1 (fr) | 1998-04-01 |
| WO1998011890A1 (en) | 1998-03-26 |
| UY24717A1 (es) | 2001-08-27 |
| EA199900306A1 (ru) | 1999-08-26 |
| DE69729735D1 (de) | 2004-08-05 |
| ID23175A (id) | 2000-03-23 |
| ES2223075T3 (es) | 2005-02-16 |
| NO991292D0 (no) | 1999-03-17 |
| TR199900527T2 (xx) | 1999-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN172468B (de) | ||
| AU2001236904A1 (en) | Deep brain stimulation system for the treatment of parkinson's disease or other disorders | |
| EP0792156A4 (de) | Verfahren zur vorbeugung oder behandlung von vaskulären hämorragien und der alzheimerischen krankheit | |
| AU2001273574A1 (en) | Substituted 5-alkynyl pyrimidines having neurotrophic activity | |
| WO1998020864A3 (en) | Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases | |
| GB0108592D0 (en) | Therapeutic agents | |
| AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
| WO2001009118A3 (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
| FR2706767B1 (de) | ||
| AU2160492A (en) | Treatment of human diseases involving dysregulation or dysfunction of the nervous system | |
| BG103252A (en) | The use of benzopyranols for the treatment of neurological disorders | |
| IL110943A (en) | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders | |
| IL142900A0 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
| ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
| SG134170A1 (en) | Method of treating of demyelinating diseases or conditions | |
| EP1032556A4 (de) | Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung | |
| WO2000021513A3 (en) | Methods for treating multiple sclerosis | |
| GB9425730D0 (en) | Compounds | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| IL130586A0 (en) | IL6RIL6 chimera for the treatment of demyelinating diseases | |
| AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
| BG102079A (en) | Alkylaminoderivatives of substituted quinoxalin-2,3-dions such as glutamatereceptor antagonists | |
| WO2003020221A3 (en) | Method of treating cancerous disease |